Literature DB >> 18814006

Effect of Reteplase and PAI-1 antibodies on postoperative adhesion formation in a laparoscopic mouse model.

Maria Mercedes Binda1, Bart W J Hellebrekers, Paul J Declerck, Philippe Robert Koninckx.   

Abstract

BACKGROUND: Postoperative adhesions remain an important clinical problem, accounting for infertility, chronic pain and bowel obstruction. Its prevention is still inadequate and overall poorly understood. The aim of this study was to investigate the effect of Reteplase (a recombinant plasminogen activator, r-PA) and of PAI-1 antibodies upon adhesion formation in a laparoscopic model.
METHODS: Pneumoperitoneum-enhanced adhesions were induced by performing a bipolar lesion in female BALB/c mice and by using pure and humidified CO(2) as insufflation gas for 60 min. In experiment 1, four doses of 0.125, 0.25, 0.5 and 1 mg/0.5 ml r-PA and one and two doses of 1 mg r-PA were administrated i.p. Two control groups were included, one without any treatment and the second one receiving four times 0.5 ml of saline. In experiment 2, four doses of 0, 1, 10 and 100 microg/0.5 ml r-PA were administrated i.p. In experiment 3, PAI-1 neutralising and non-neutralising antibodies were injected i.p. after performing the lesion on day 0 and days 2 and 4. Adhesions were scored after 7 days.
RESULTS: Adhesion formation was less with the administration of four doses of 1 microg r-PA (proportion, p < 0.04, Wilcoxon). An increase in adhesion formation was observed when higher number of doses and amounts of r-PA were used (Proc GLM, eight groups, two variables, p = 0.05 for the amount of r-PA and p < 0.02 for the number of doses administrated). No effect was observed with the PAI-1 antibodies.
CONCLUSIONS: Low-dose i.p. administration of rPA is effective in the prevention of adhesions in a laparoscopic mouse model.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18814006     DOI: 10.1007/s00464-008-0111-x

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  29 in total

1.  Neutralization of plasminogen activator inhibitor-1 inhibitory properties: identification of two different mechanisms.

Authors:  S Debrock; P J Declerck
Journal:  Biochim Biophys Acta       Date:  1997-02-08

2.  Inhibition of plasminogen activator inhibitor-1 activity results in promotion of endogenous thrombolysis and inhibition of thrombus extension in models of experimental thrombosis.

Authors:  M Levi; B J Biemond; A J van Zonneveld; J W ten Cate; H Pannekoek
Journal:  Circulation       Date:  1992-01       Impact factor: 29.690

Review 3.  Use of fibrinolytic agents in the prevention of postoperative adhesion formation.

Authors:  B W Hellebrekers; T C Trimbos-Kemper; J B Trimbos; J J Emeis; T Kooistra
Journal:  Fertil Steril       Date:  2000-08       Impact factor: 7.329

4.  Peritoneal mesothelial hypoxia during pneumoperitoneum is a cofactor in adhesion formation in a laparoscopic mouse model.

Authors:  C R Molinas; O Mynbaev; A Pauwels; P Novak; P R Koninckx
Journal:  Fertil Steril       Date:  2001-09       Impact factor: 7.329

5.  Role of the plasminogen system in basal adhesion formation and carbon dioxide pneumoperitoneum-enhanced adhesion formation after laparoscopic surgery in transgenic mice.

Authors:  Carlos Roger Molinas; Osama Elkelani; Rudi Campo; Aernout Luttun; Peter Carmeliet; Philippe Robert Koninckx
Journal:  Fertil Steril       Date:  2003-07       Impact factor: 7.329

6.  Role of vascular endothelial growth factor and placental growth factor in basal adhesion formation and in carbon dioxide pneumoperitoneum-enhanced adhesion formation after laparoscopic surgery in transgenic mice.

Authors:  Carlos Roger Molinas; Rudi Campo; Mieke Dewerchin; Ulf Eriksson; Peter Carmeliet; Philippe Robert Koninckx
Journal:  Fertil Steril       Date:  2003-09       Impact factor: 7.329

7.  Laparoscopic-type environment enhances mesothelial cell fibrinolytic activity in vitro via a down-regulation of plasminogen activator inhibitor-1 activity.

Authors:  Paul Ziprin; Paul F Ridgway; David H Peck; Ara W Darzi
Journal:  Surgery       Date:  2003-11       Impact factor: 3.982

8.  Thrombolysis and reocclusion in experimental jugular vein and coronary artery thrombosis. Effects of a plasminogen activator inhibitor type 1-neutralizing monoclonal antibody.

Authors:  B J Biemond; M Levi; R Coronel; M J Janse; J W ten Cate; H Pannekoek
Journal:  Circulation       Date:  1995-02-15       Impact factor: 29.690

9.  Antithrombotic activity of a monoclonal antibody inducing the substrate form of plasminogen activator inhibitor type 1 in rat models of venous and arterial thrombosis.

Authors:  C N Berry; C Lunven; I Lechaire; C Girardot; S E O'Connor
Journal:  Br J Pharmacol       Date:  1998-09       Impact factor: 8.739

10.  Efficacy of barriers and hypoxia-inducible factor inhibitors to prevent CO(2) pneumoperitoneum-enhanced adhesions in a laparoscopic mouse model.

Authors:  Maria Mercedes Binda; Carlos Roger Molinas; Adriana Bastidas; Marc Jansen; Philippe Robert Koninckx
Journal:  J Minim Invasive Gynecol       Date:  2007 Sep-Oct       Impact factor: 4.137

View more
  1 in total

Review 1.  Adhesion formation after laparoscopic surgery: what do we know about the role of the peritoneal environment?

Authors:  C R Molinas; M M Binda; G D Manavella; P R Koninckx
Journal:  Facts Views Vis Obgyn       Date:  2010
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.